Gallbladder Inflammation (Cholecystitis)
For acute cholecystitis, early laparoscopic cholecystectomy performed within 7-10 days of symptom onset is the definitive treatment of choice, offering superior outcomes compared to delayed surgery or conservative management. 1, 2
Diagnosis of Acute Cholecystitis
Clinical Presentation
- Right upper quadrant pain
- Fever and leukocytosis
- Murphy's sign (pain on palpation during inspiration)
- Nausea/vomiting 1
Diagnostic Imaging
Ultrasound is the first-line imaging modality with approximately 81% sensitivity and 83% specificity 3, 4. Key findings include:
- Pericholecystic fluid
- Distended gallbladder with thickened wall (>3mm)
- Gallstones, particularly impacted in cystic duct
- Positive sonographic Murphy's sign 1, 5
If ultrasound is equivocal and clinical suspicion remains high, hepatobiliary scintigraphy (HIDA scan) is the gold standard for confirming acute cholecystitis 3, 4. CT with IV contrast should be obtained if complications are suspected or alternative diagnoses need exclusion 3.
Management Strategy
Uncomplicated Cholecystitis
Early laparoscopic cholecystectomy (within 7 days of hospital admission and 10 days of symptom onset) is strongly recommended 1, 2. This approach provides:
- Shorter hospital stays (5.4 vs 10.0 days for delayed surgery)
- Fewer postoperative complications (11.8% vs 34.4%)
- Lower hospital costs
- Greater patient satisfaction 1, 4
No postoperative antibiotics are necessary if source control is complete 1.
Complicated Cholecystitis
Laparoscopic cholecystectomy remains first-line, with open cholecystectomy as alternative 5. Antibiotic duration:
- 4 days for immunocompetent, non-critically ill patients with adequate source control
- Up to 7 days for immunocompromised or critically ill patients, based on clinical response 5
High-Risk/Critically Ill Patients
Laparoscopic cholecystectomy is superior to percutaneous cholecystostomy even in high-risk patients 2. The CHOCOLATE trial demonstrated that early laparoscopic cholecystectomy resulted in significantly fewer major complications (5% vs 53%) compared to percutaneous drainage 2.
Cholecystostomy should be reserved only for patients truly unfit for any surgery, though it carries higher complication rates (65% vs 12% for laparoscopic cholecystectomy) 1, 4.
Special Populations
Pregnant patients: Early laparoscopic cholecystectomy is recommended during all trimesters, with lower maternal-fetal complications (1.6% vs 18.4% for delayed management) 4.
Elderly patients (>65 years): Laparoscopic cholecystectomy shows lower 2-year mortality (15.2%) compared to nonoperative management (29.3%) 4.
Risk Factors for Conversion to Open Surgery
Be aware that these factors increase conversion risk:
- Age >65 years
- Male gender
- Thickened gallbladder wall
- Diabetes mellitus
- Previous upper abdominal surgery 1
Critical Complication: Gallbladder Perforation
Early diagnosis and immediate surgical intervention are essential to reduce the 12-16% mortality rate associated with perforation 1. CT is more reliable than ultrasound for detecting the "hole sign" and pericholecystic collections 1.
Gastritis
Atrophic gastritis requires histopathologic confirmation and should prompt evaluation for H. pylori infection and, if features suggest autoimmune etiology, assessment for vitamin B12 and iron deficiency 6.
Diagnosis of Atrophic Gastritis
Definition
Loss of gastric glands with or without metaplasia in the setting of chronic inflammation, primarily from:
- H. pylori infection (most common)
- Autoimmune gastritis 6
Endoscopic Features
- Pale gastric mucosa
- Increased visibility of vasculature (mucosal thinning)
- Loss of gastric folds
- Light blue crests and white opaque fields (if intestinal metaplasia present) 6
Histopathologic Confirmation
The presence of intestinal metaplasia on gastric biopsy almost invariably indicates underlying atrophic gastritis, though this is often not explicitly stated in pathology reports 6.
Obtain biopsies from body and antrum/incisura in separately labeled jars, plus targeted biopsies from any mucosal abnormalities 6.
Management
H. pylori Assessment
All patients with atrophic gastritis must be tested for H. pylori 6. If positive:
- Administer eradication therapy
- Confirm successful eradication with non-serological testing
Autoimmune Gastritis Workup
If histology suggests autoimmune etiology:
- Check anti-parietal cell antibodies
- Check anti-intrinsic factor antibodies
- Evaluate for vitamin B12 deficiency (check pepsinogen I levels and gastrin)
- Evaluate for iron deficiency anemia
- Screen for associated autoimmune conditions (thyroid disease, type 1 diabetes) 6, 7
Surveillance
For advanced atrophic gastritis (extensive anatomic distribution and high histologic grade), consider endoscopic surveillance every 3 years due to increased gastric cancer risk 6.
Important Distinction: Bile Reflux Gastritis
Post-cholecystectomy patients may develop bile reflux gastritis (prevalence 61.8% vs 16.7% in controls), particularly if obese or diabetic 8. This is a separate entity from atrophic gastritis and presents with refractory upper abdominal pain, bloating, and bile regurgitation 8.